开发一项复杂的干预措施,以支持治疗囊性纤维化糖尿病的患者
Sarah Collins1, Andrew Jones2, Rita Forde3
1Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London SE1 8WA, United Kingdom; Royal Brompton & Harefield Hospitals, London SW3 6NP, United Kingdom.
Patient education and counseling
|November 28, 2025
概括
针对囊性纤维化糖尿病 (CFD) 开发了一项新的基于网络的自我管理教育计划,称为MAGIC. 该计划旨在提高CFD患者的自我管理技能,CFD是囊性纤维化患者常见的并发症.
科学领域:
- 医学研究 医学研究
- 卫生教育卫生教育教育
- 慢性疾病管理 慢性疾病管理
背景情况:
- 囊性纤维化糖尿病 (CFD) 是患有囊性纤维化 (CF) 的成年人中普遍存在的并发症.
- 目前英国的指导方针缺乏CFD的自我管理教育计划.
- 需要有效的资源来支持CFD管理.
研究的目的:
- 描述一个新的自我管理教育计划的发展,用于CFD的个人.
- 创建一个以患者为中心,分阶段学习的方法来管理非正常的葡萄糖在CF.
主要方法:
- 利用医学研究委员会 (MRC) 框架进行复杂的干预开发.
- 涉及三个阶段的开发过程:证据基础识别,理论开发和过程/结果建模.
- 参与了医疗保健专业人员和个人与CFD相关的利益相关者小组.
主要成果:
- 开发了MAGIC (CF中异常葡萄糖的管理) 计划,这是一个由四个模块组成的基于网络的干预.
- 该程序采用阶段式学习方法 (初学者,改进者,进步者,向导).
- 最初的参与者审查表明高度重视,所有技术和理解问题都得到了解决.
结论:
- 在使用MRC框架的前提下,MAGIC计划成功地开发出来.
- 它是以证据为基础的,包括系统审查,采访和专家/患者经验.
- 该计划显示CFD自我管理的希望,需要进一步的适应和有效性研究.
相关概念视频
Cystic Fibrosis: Management
447
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
447
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Chronic Pancreatitis II: Collaborative Care
291
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
291
Cystic Fibrosis: Pathogenesis
680
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
680
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Chronic Kidney Disease IV: Nursing Management
299
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
299


